Home › Funds › HighVista Strategies LLC › GPCR

HighVista Strategies LLC position in GPCR

STRUCTURE THERAPEUTICS INC · Health Care

HighVista Strategies LLC reported holding 170,193 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.3M, representing 1.40% of its reported portfolio and ranking #17 among its reported holdings. HighVista Strategies LLC has disclosed GPCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)170.19K sh
Reported value held$5.32M
Portfolio Weight1.40%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HighVista Strategies LLC's GPCR position evolved

HighVista Strategies LLC first disclosed a stake in GPCR in Q3 2023 at 74,832 shares (US$3.8M). The position peaked in Q4 2025 at 193,001 shares, worth US$13.4M. Across 13 filings, HighVista Strategies LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 170,193 shares valued at US$5.3M — an increase of 39,409 shares quarter over quarter.. Notable position changes include a 50% trim in Q1 2024 (shares fell 8% over the following quarter), a 393% increase in Q2 2025 (shares rose 35% over the following quarter), a 173% increase in Q3 2025 (shares rose 148% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 74.83K $3.77M New
Q4 2023 74.83K $3.05M Hold
Q1 2024 37.44K $1.60M Reduce
Q2 2024 35.13K $1.38M Reduce
Q3 2024 31.72K $1.39M Reduce
Q4 2024 17.56K $476.25K Reduce
Q1 2025 17.56K $303.98K Hold
Q2 2025 86.62K $1.80M Add
Q3 2025 236.24K $6.61M Add
Q4 2025 193.00K $13.42M Reduce
Q1 2026 123.91K $5.97M Reduce
Q2 2026 130.78K $7.02M Add
Q3 2026 170.19K $5.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GPCR and 13F data

GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 29 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GPCR

All GPCR fund holders →

FAQ

How long has HighVista Strategies LLC held GPCR?

HighVista Strategies LLC has disclosed GPCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HighVista Strategies LLC's current position in GPCR?

As of Q3 2026, HighVista Strategies LLC holds 170.19K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $5.32M, representing 1.40% of its reported portfolio and ranking #17.

Has HighVista Strategies LLC been buying or selling GPCR?

In the latest 13F filing (Q3 2026), HighVista Strategies LLC increased its position in GPCR. The position peaked in Q4 2025 at 193.00K shares.

Which other funds hold GPCR?

Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.